Since 1981, AFAR has provided over $172 million to over 4,000 talented investigators and students. To learn more about each grant, click below or contact the AFAR grant program staff at email@example.com.
The New Investigator Awards in Alzheimer's Disease
Please note: The deadline for Letters of Intent is March 6, 2017.
Funded by The Rosalinde and Arthur Gilbert Foundation, the major goal of this partnership program is to support important research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, and treatment of Alzheimer's disease. The program also serves to encourage junior investigators in the United States and Israel to pursue research and academic careers in the neurosciences, and Alzheimer's disease and healthy brain aging in particular.
The program will fund applications in basic, translational and clinical research related to Alzheimer’s disease and healthy brain aging. Research that shows high promise for translating basic biomedical knowledge to prevention or new treatments is of particular interest.
Examples of promising areas of research include, but are not limited to:
- Genetic and environmental risk/protective factors
- Cellular and molecular pathways
- Cardiovascular and cerebrovascular factors
- Neuroimaging and other biomarkers
- Cellular, animal and in silico models
- Diagnostic and prognostic markers
- Exercise, nutrition, and dietary factors
- Drug discovery and other therapeutics
- Learning and memory
- The biology and pathobiology of synapses
- Neurogenesis, neural and glial progenitors
It is anticipated that up to 3 grants of $100,000 each will be awarded in 2017. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Up to 8% of funds may be budgeted for overhead or indirect costs (not to exceed $7,407). Funding will begin July 1, 2017.
The applicant must be an independent investigator in the United States or Israel with independent research space as described in the Institutional Commitment Form completed by the Dean or Department Chair, and must be no more than 10 years beyond start of postdoctoral research training as of July 1, 2017. Exceptions to the ten year rule may be requested for unusual circumstances by emailing an NIH-style biosketch to AFAR at firstname.lastname@example.org at least one week prior to the submission deadline. The proposed research must be conducted at any type of not-for-profit setting in the United States or Israel.
The New Investigator Awards in Alzheimer's Disease do not provide support for:
- Postdoctoral fellows in the laboratory of a senior investigator
- Investigators who have already received major extramural funding (such as an R01 or NSF equivalent grant) prior to and up until the start date of the award
- Senior faculty, i.e. at the rank of Associate Professor level or higher
- Federal employees
- Applicants who are conducting research at a for-profit institution, or at an institution outside of the United States or Israel
Applications for this program may be considered for the AFAR Research Grant for Junior Faculty if deemed competitive.
Five criteria are used to determine the merit of an application:
- Qualifications of the applicant;
- Quality of the proposed research;
- Relevance of the proposal to Alzheimer's disease or healthy brain aging;
- Excellence of the research environment;
- Likelihood that the project will advance the applicant's career in Alzheimer's Disease or healthy brain aging
For one of the awards, priority may be given to an investigator with a research project that has great translational potential provided the application is deemed to meet the highest standards set by AFAR's Review Committee.
If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.
The deadline for receipt of all Letters of Intent is March 6, 2017 at 5:00 p.m. EST. Please refer to the New Investigator LOI instructions. Incomplete LOIs cannot be considered. All Letters of Intent and Institutional Commitment Forms must be submitted through to email@example.com. The Letters of Intent will be reviewed by a committee. Applicants will be notified by early April, and a subset of applicants will be invited to submit a full application by early May.
Click here for our Frequently Ask Questions page.
All LOI candidates who are invited to submit applications must have it endorsed by their institution. Final awards are announced by mid-June. The award start date is July 1, 2017. AFAR will not provide reviewer critiques to any applicants at any review level.
Investigators will be required to submit a brief narrative report on the progress of their research five months after the start date of the award. Final narrative and financial reports are required within three months following the end date of the award.
The award recipients are expected to attend the AFAR Grantee Conference which convenes AFAR grant recipients, mentors and leaders in the field to review and disseminate the research progress of the grantees and their findings. The meeting encourages networking, facilitates collaborations, and enhances the development of leadership. In addition, grant recipients of the New Investigator Awards in Alzheimer's are expected to attend a special session at the grantee conference.
The Rosalinde and Arthur Gilbert Foundation is committed to providing resources to organizations that promote and improve health, education, economic, and cultural opportunities to communities in California, the U.S. and Israel.
The Rosalinde and Arthur Gilbert Foundation supports:
- College access and retention in Greater Los Angeles
- Education, economic development, and scientific research in Israel
- Diabetes prevention and healthy land use in Greater Los Angeles
- Alzheimer’s Disease research in the U.S and Israel and caregiver support in the U.S.
- Cultural organizations and arts education programs in Greater Los Angeles
- Jewish Life organizations in Greater Los Angeles
- Programs at UC Berkeley and UCLA that intersect with the Foundation’s mission and objectives.
To leverage its commitments, The Rosalinde and Arthur Gilbert Foundation partners with other funders, government agencies, and local and international philanthropists.